Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Conduit Pharma Inc | Dr. Andrew James Regan, PhD | Director, Chief Executive Officer | 30 Jul 2026 | 5,436,830 | 5,436,830 | - | - | Pre-Funded Warrants | ||
| Conduit Pharma Inc | Dr. Andrew James Regan, PhD | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 30 Jul 2026 | 5,436,830 | 5,693,223 | - | - | Common Stock | |
| Conduit Pharma Inc | Dr. Andrew James Regan, PhD | Director, Chief Executive Officer | 30 Jul 2026 | 5,436,830 | 0 | - | - | Pre-Funded Warrants | ||
| SoundHound AI Inc (Class A) | Dr. Keyvan Mohajer, PhD | Director, CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 1,500,000 | 3,447,237 | - | 0 | Class A Common Stock | |
| OneMedNet Corp (Class A) | Dr. Thomas Kosasa, M.D. | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.69 per share. | 30 Jul 2026 | 1,449,275 | 18,538,150 | - | 0.7 | 1,000,000 | Common Stock |
| Apnimed Inc | Mr. Kevin R. Lind | Director, Chief Executive Officer | 30 Jul 2026 | 1,186,278 | 1,186,278 | - | - | Stock Option (Right to Buy) | ||
| Apnimed Inc | Mr. Kevin R. Lind | Director, Chief Executive Officer | 30 Jul 2026 | 1,186,278 | 0 | - | - | Stock Option (Right to Buy) | ||
| SoundHound AI Inc (Class A) | Mr. Michael Zagorsek | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 750,000 | 2,421,344 | - | 0 | Class A Common Stock | |
| SoundHound AI Inc (Class A) | Mr. James M. Hom | Director, Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 400,000 | 1,144,285 | - | 0 | Class A Common Stock | |
| SoundHound AI Inc (Class A) | Dr. Majid Emami, PhD | CSO & SVP, Engineering, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 400,000 | 872,983 | - | 0 | Class A Common Stock | |
| SoundHound AI Inc (Class A) | Dr. Keyvan Mohajer, PhD | Director, CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 375,000 | 3,822,237 | - | 0 | Class A Common Stock | |
| Cosmos Health Inc | Mr. Grigorios Siokas | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.20 per share. | 30 Jul 2026 | 349,825 | 14,597,917 | - | 0.2 | 70,000 | Common Stock, par value $.001 |
| Apnimed Inc | Mr. Michael B. Kelly | Chief Financial Officer | 30 Jul 2026 | 333,580 | 0 | - | - | Stock Option (Right to Buy) | ||
| Apnimed Inc | Mr. Michael B. Kelly | Chief Financial Officer | 30 Jul 2026 | 333,580 | 333,580 | - | - | Stock Option (Right to Buy) | ||
| Apnimed Inc | Mr. Dennis Patrick Molnar | President | 30 Jul 2026 | 330,210 | 330,210 | - | - | Stock Option (Right to Buy) | ||
| Apnimed Inc | Mr. Dennis Patrick Molnar | President | 30 Jul 2026 | 330,210 | 0 | - | - | Stock Option (Right to Buy) | ||
| Jersey Mikes Subs Inc | Ms. Stacy Peterson | President and COO | 30 Jul 2026 | 272,135 | 272,135 | - | - | Incentive Units of Jersey Mikes HoldCo, LLC | ||
| Jersey Mikes Subs Inc | Ms. Michele Allen | Chief Financial Officer | 30 Jul 2026 | 272,135 | 272,135 | - | - | Incentive Units of Jersey Mikes HoldCo, LLC | ||
| Mueller Ind Inc | Mr. Gregory L. Christopher | Director, Chairman of the Board & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 270,000 | 1,879,822 (3%) | 0% | 0 | Common Stock | |
| SoundHound AI Inc (Class A) | Mr. Michael Zagorsek | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 250,000 | 2,671,344 | - | 0 | Class A Common Stock | |
| Strata Critical Medical Inc (Class A) | Dr. Melissa M. Tomkiel | Director, Co-CEO and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.09 per share. | 30 Jul 2026 | 212,309 | 2,096,347 | - | 5.1 | 1,080,653 | Class A common stock, $0.0001 par value per share |
| Strata Critical Medical Inc (Class A) | Dr. Melissa M. Tomkiel | Director, Co-CEO and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 208,929 | 2,101,703 | - | 0 | Class A common stock, $0.0001 par value per share | |
| Strata Critical Medical Inc (Class A) | Dr. Melissa M. Tomkiel | Director, Co-CEO and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 206,953 | 2,308,656 | - | 0 | Class A common stock, $0.0001 par value per share | |
| Mueller Ind Inc | Mr. Gregory L. Christopher | Director, Chairman of the Board & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.57 per share. | 30 Jul 2026 | 205,972 | 1,673,850 (2%) | 0% | 66.6 | 13,711,556 | Common Stock |
| Strata Critical Medical Inc (Class A) | Mr. William A. Heyburn | Director, Co-CEO and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.09 per share. | 30 Jul 2026 | 199,209 | 1,710,019 | - | 5.1 | 1,013,974 | Class A common stock, $0.0001 par value per share |
| Waldencast PLC (Class A) | Ms. Hind Sebti | Director, Chief Growth Officer | 30 Jul 2026 | 193,816 | 0 | - | - | Restricted Stock Units | ||
| Jersey Mikes Subs Inc | Ms. Betsy J. Mercado | Chief People Officer | 30 Jul 2026 | 190,495 | 190,495 | - | - | Incentive Units of Jersey Mikes HoldCo, LLC | ||
| Strata Critical Medical Inc (Class A) | Mr. William A. Heyburn | Director, Co-CEO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 181,071 | 1,730,068 | - | 0 | Class A common stock, $0.0001 par value per share | |
| Strata Critical Medical Inc (Class A) | Mr. William A. Heyburn | Director, Co-CEO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 179,160 | 1,909,228 | - | 0 | Class A common stock, $0.0001 par value per share | |
| Apnimed Inc | Mr. Dennis Patrick Molnar | President | 30 Jul 2026 | 148,788 | 0 | - | - | Stock Option (Right to Buy) | ||
| Apnimed Inc | Mr. Dennis Patrick Molnar | President | 30 Jul 2026 | 148,788 | 148,788 | - | - | Stock Option (Right to Buy) | ||
| Entrada Therapeutics Inc | Dr. Kush M. Parmar, M.D.,PhD | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.93 per share. | 30 Jul 2026 | 114,756 | 2,848,310 | - | 6.9 | 795,259 | Common Stock |
| Apnimed Inc | Mr. Kevin R. Lind | Director, Chief Executive Officer | 30 Jul 2026 | 108,916 | 108,916 | - | - | Stock Option (Right to Buy) | ||
| Apnimed Inc | Mr. Kevin R. Lind | Director, Chief Executive Officer | 30 Jul 2026 | 108,916 | 0 | - | - | Stock Option (Right to Buy) | ||
| Apnimed Inc | Mr. Kevin R. Lind | Director, Chief Executive Officer | 30 Jul 2026 | 108,916 | 108,916 | - | - | Stock Option (Right to Buy) | ||
| Motorsport Games Inc (Class A) | Mr. Stephen Hood | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 100,000 | 100,000 | - | 0 | Class A Common Stock | |
| LiveWire Grp Inc | Dr. Kjell Gruner, PhD | Director | Sale of securities on an exchange or to another person at price $ 2.11 per share. | 30 Jul 2026 | 94,091 | 108,227 | - | 2.1 | 198,532 | Common Stock |
| Associated Banc-Corp. | Mr. Randall J. Erickson | Executive Vice President | Sale of securities on an exchange or to another person at price $ 30.76 per share. | 30 Jul 2026 | 90,573 | 48,542 (0%) | 0% | 30.8 | 2,785,573 | Common Stock $0.01 Par Value |
| Cactus Inc (Class A) | Mr. Scott Bender | Director, Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 57.62 per share. | 30 Jul 2026 | 86,700 | 120,527 (0%) | 0% | 57.6 | 4,995,481 | Class A Common Stock |
| Cactus Inc (Class A) | Mr. Joel Bender | Director, President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 57.62 per share. | 30 Jul 2026 | 86,700 | 41,519 (0%) | 0% | 57.6 | 4,995,481 | Class A Common Stock |
| Jersey Mikes Subs Inc | Mr. Nigel Travis | Director, Chairman | 30 Jul 2026 | 84,954 | 84,954 | - | - | Incentive Units of Jersey Mikes HoldCo, LLC | ||
| Corcept Therapeutics Inc | Mr. Atabak Mokari | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.06 per share. | 30 Jul 2026 | 80,000 | 96,130 (0%) | 0% | 23.1 | 1,844,800 | Common Stock |
| Corcept Therapeutics Inc | Mr. Atabak Mokari | Chief Financial Officer | 30 Jul 2026 | 80,000 | 95,833 | - | - | Stock option (right to buy) | ||
| GM | Mr. Grant Michael Dixton | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2026 | 79,132 | 130,048 (0%) | 0% | 0 | Common Stock | |
| GM | Mr. Grant Michael Dixton | Executive Vice President | 30 Jul 2026 | 79,132 | 0 | - | - | Restricted Stock Units | ||
| Motorsport Games Inc (Class A) | Mr. Andrew P. Jacobson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 77,246 | 77,246 | - | 0 | Class A Common Stock | |
| Jetblue Airways Corp | Ms. Ursula Hurley | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 5.75 per share. | 30 Jul 2026 | 74,276 | 211,099 (0%) | 0% | 5.8 | 427,087 | Common Stock |
| Apnimed Inc | Mr. Kevin R. Lind | Director, Chief Executive Officer | 30 Jul 2026 | 74,128 | 74,128 | - | - | Stock Option (Right to Buy) | ||
| Apnimed Inc | Mr. Kevin R. Lind | Director, Chief Executive Officer | 30 Jul 2026 | 74,128 | 0 | - | - | Stock Option (Right to Buy) | ||
| Mueller Ind Inc | Mr. Jeffrey A. Martin | EVP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 72,000 | 682,716 (1%) | 0% | 0 | Common Stock | |
| Motorsport Games Inc (Class A) | Mr. Navtej Singh Sunner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 69,567 | 69,567 | - | 0 | Class A Common Stock | |
| Cheesecake Factory Inc | Clark Matthew Eliot | EXEC VP, CFO | Sale of securities on an exchange or to another person at price $ 99.30 per share. | 30 Jul 2026 | 68,900 | 45,109 (0%) | 0% | 99.3 | 6,841,770 | Common Stock |
| Cheesecake Factory Inc | Clark Matthew Eliot | EXEC VP, CFO | 30 Jul 2026 | 68,900 | 0 | - | - | Employee Stock Option (Right to Buy) | ||
| Cheesecake Factory Inc | Clark Matthew Eliot | EXEC VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.16 per share. | 30 Jul 2026 | 68,900 | 114,009 (0%) | 0% | 40.2 | 2,767,024 | Common Stock |
| Motorsport Games Inc (Class A) | Mr. Guoquan Paul Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 64,663 | 246,481 | - | 0 | Class A Common Stock | |
| Motorsport Games Inc (Class A) | Mr. John Delta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 62,458 | 74,458 | - | 0 | Class A Common Stock | |
| SEACOR Marine Holdings Inc | Mr. Jesus Llorca | EVP & CFO | Sale of securities on an exchange or to another person at price $ 9.12 per share. | 30 Jul 2026 | 60,823 | 411,818 (1%) | 0% | 9.1 | 554,706 | Common Stock |
| Apnimed Inc | Mr. Dennis Patrick Molnar | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 58,014 | 58,014 | - | - | Common Stock | |
| Apnimed Inc | Mr. Dennis Patrick Molnar | President | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Jul 2026 | 58,014 | 0 | - | - | Class A Common Stock | |
| Mueller Ind Inc | Mr. Jeffrey A. Martin | EVP, CFO & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.57 per share. | 30 Jul 2026 | 57,791 | 624,925 (1%) | 0% | 66.6 | 3,847,147 | Common Stock |
| Strata Critical Medical Inc (Class A) | Mr. Scott. M Wunsch | CEO, Logistics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 57,172 | 682,746 | - | 0 | Class A common stock, $0.0001 par value per share | |
| Apnimed Inc | Mr. Dennis Patrick Molnar | President | 30 Jul 2026 | 55,596 | 55,596 | - | - | Stock Option (Right to Buy) | ||
| Apnimed Inc | Mr. Dennis Patrick Molnar | President | 30 Jul 2026 | 55,596 | 55,596 | - | - | Stock Option (Right to Buy) | ||
| Apnimed Inc | Mr. Dennis Patrick Molnar | President | 30 Jul 2026 | 55,596 | 0 | - | - | Stock Option (Right to Buy) | ||
| Curbline Properties Corp | Mr. Conor M. Fennerty | EVP, CFO & Treasurer | Sale of securities on an exchange or to another person at price $ 30.38 per share. | 30 Jul 2026 | 55,105 | 153,909 | - | 30.4 | 1,674,200 | Common Stock |
| reAlpha Tech Corp | Mr. Michael J. Logozzo | Director, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 52,296 | 195,799 | - | 0 | Common Stock | |
| Apnimed Inc | Mr. Gary L. Sender | Director | 30 Jul 2026 | 51,890 | 0 | - | - | Stock Option (Right to Buy) | ||
| Apnimed Inc | Mr. Gary L. Sender | Director | 30 Jul 2026 | 51,890 | 51,890 | - | - | Stock Option (Right to Buy) | ||
| Apnimed Inc | Mr. Paul Fonteyne, M.S. | Director | 30 Jul 2026 | 51,890 | 0 | - | - | Stock Option (Right to Buy) | ||
| Apnimed Inc | Mr. Paul Fonteyne, M.S. | Director | 30 Jul 2026 | 51,890 | 51,890 | - | - | Stock Option (Right to Buy) | ||
| Cue Biopharma Inc | Mr. James M. Ahlers | Chief Financial Officer | 30 Jul 2026 | 51,000 | 51,000 | - | - | Stock Option (Right to Buy) | ||
| Jersey Mikes Subs Inc | Mr. Nigel Travis | Director, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 50,300 | 50,300 | - | - | Class B Common Stock | |
| Jersey Mikes Subs Inc | Mr. Nigel Travis | Director, Chairman | 30 Jul 2026 | 50,300 | 50,300 | - | - | Common Units of Jersey Mikes HoldCo, LLC | ||
| Strata Critical Medical Inc (Class A) | Mr. Robert S. Wiesenthal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 50,234 | 5,325,896 | - | 0 | Class A common stock, $0.0001 par value per share | |
| Heron Therapeutics Inc | Mr. Craig A. Collard | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2026 | 50,021 | 821,703 (0%) | 0% | - | Common Stock | |
| Heron Therapeutics Inc | Mr. Craig A. Collard | Director, Chief Executive Officer | 30 Jul 2026 | 50,021 | 700,295 | - | - | Restricted Stock Units | ||
| reAlpha Tech Corp | Mr. Thomas J. Kutzman, Jr | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 47,938 | 100,798 | - | 0 | Common Stock | |
| SEACOR Marine Holdings Inc | Mr. Andrew H. Everett, II | Sr. VP, General Counsel & Secy | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 30 Jul 2026 | 45,892 | 223,595 (1%) | 0% | 9 | 413,028 | Common Stock |
| Grocery Outlet Holding Corp | Ms. Carey F. Jaros | Director | Other type of transaction at price $ 0.00 per share. | 30 Jul 2026 | 45,000 | 45,000 (0%) | 0% | 0 | Common Stock | |
| Grocery Outlet Holding Corp | Ms. Carey F. Jaros | Director | Other type of transaction at price $ 0.00 per share. | 30 Jul 2026 | 45,000 | 49,934 (0%) | 0% | 0 | Common Stock | |
| Apnimed Inc | Mr. Gary L. Sender | Director | 30 Jul 2026 | 44,477 | 44,477 | - | - | Stock Option (Right to Buy) | ||
| Apnimed Inc | Mr. Gary L. Sender | Director | 30 Jul 2026 | 44,477 | 44,477 | - | - | Stock Option (Right to Buy) | ||
| Apnimed Inc | Mr. Gary L. Sender | Director | 30 Jul 2026 | 44,477 | 0 | - | - | Stock Option (Right to Buy) | ||
| Apnimed Inc | Mr. Gary L. Sender | Director | 30 Jul 2026 | 44,477 | 44,477 | - | - | Stock Option (Right to Buy) | ||
| Apnimed Inc | Mr. Gary L. Sender | Director | 30 Jul 2026 | 44,477 | 0 | - | - | Stock Option (Right to Buy) | ||
| Apnimed Inc | Mr. Paul Fonteyne, M.S. | Director | 30 Jul 2026 | 44,477 | 44,477 | - | - | Stock Option (Right to Buy) | ||
| Apnimed Inc | Mr. Paul Fonteyne, M.S. | Director | 30 Jul 2026 | 44,477 | 0 | - | - | Stock Option (Right to Buy) | ||
| Apnimed Inc | Mr. Paul Fonteyne, M.S. | Director | 30 Jul 2026 | 44,477 | 44,477 | - | - | Stock Option (Right to Buy) | ||
| Apnimed Inc | Mr. Paul Fonteyne, M.S. | Director | 30 Jul 2026 | 44,477 | 0 | - | - | Stock Option (Right to Buy) | ||
| Apnimed Inc | Mr. Paul Fonteyne, M.S. | Director | 30 Jul 2026 | 44,477 | 44,477 | - | - | Stock Option (Right to Buy) | ||
| Strata Critical Medical Inc (Class A) | Mr. William L. Cook, III | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 44,438 | 97,671 | - | 0 | Class A common stock, $0.0001 par value per share | |
| reAlpha Tech Corp | Mr. Giri Devanur | Director, Executive Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 43,580 | 1,093,644 | - | 0 | Common Stock | |
| Apnimed Inc | Mr. Dennis Patrick Molnar | President | 30 Jul 2026 | 42,240 | 0 | - | - | Stock Option (Right to Buy) | ||
| Apnimed Inc | Mr. Dennis Patrick Molnar | President | 30 Jul 2026 | 42,240 | 42,240 | - | - | Stock Option (Right to Buy) | ||
| Strata Critical Medical Inc (Class A) | Mr. Amir M. Cohen | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 41,786 | 188,394 | - | 0 | Class A common stock, $0.0001 par value per share | |
| Marathon Digital Holdings Inc | Mr. Frederick G. Thiel | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.82 per share. | 30 Jul 2026 | 40,497 | 4,430,906 (56%) | 0% | 11.8 | 478,675 | Common Stock |
| GM | Mr. Grant Michael Dixton | Executive Vice President | Sale of securities on an exchange or to another person at price $ 88.44 per share. | 30 Jul 2026 | 40,000 | 54,992 (0%) | 0% | 88.4 | 3,537,600 | Common Stock |
| Bridgewater Bancshares Inc | Ms. Mary Jayne Crocker | Director | 30 Jul 2026 | 39,958 | 51,113 | - | - | Option to buy | ||
| Bridgewater Bancshares Inc | Ms. Mary Jayne Crocker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.47 per share. | 30 Jul 2026 | 39,958 | 249,959 (0%) | 0% | 7.5 | 298,486 | Common Stock |
| Strata Critical Medical Inc (Class A) | Mr. Reginald L. Love | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 37,675 | 151,572 | - | 0 | Class A common stock, $0.0001 par value per share | |
| Visa | Ms. Kelly Mahon Tullier | VICE CHAIR, CHF PPL & CORP AFF | 30 Jul 2026 | 37,281 | 0 | - | - | Employee Stock Option (Right to Buy) | ||
| Visa | Ms. Kelly Mahon Tullier | VICE CHAIR, CHF PPL & CORP AFF | Sale of securities on an exchange or to another person at price $ 365.05 per share. | 30 Jul 2026 | 37,281 | 69,653 (0%) | 0% | 365.0 | 13,609,399 | Class A Common Stock |
| Visa | Ms. Kelly Mahon Tullier | VICE CHAIR, CHF PPL & CORP AFF | Exercise or conversion of derivative security received from the company (such as an option) at price $ 109.82 per share. | 30 Jul 2026 | 37,281 | 106,934 (0%) | 0% | 109.8 | 4,094,199 | Class A Common Stock |
| Apnimed Inc | Mr. Dennis Patrick Molnar | President | 30 Jul 2026 | 37,064 | 0 | - | - | Stock Option (Right to Buy) | ||
| Apnimed Inc | Mr. Dennis Patrick Molnar | President | 30 Jul 2026 | 37,064 | 37,064 | - | - | Stock Option (Right to Buy) | ||
| Apnimed Inc | Mr. Dennis Patrick Molnar | President | 30 Jul 2026 | 37,064 | 0 | - | - | Stock Option (Right to Buy) | ||
| Apnimed Inc | Mr. Dennis Patrick Molnar | President | 30 Jul 2026 | 37,064 | 37,064 | - | - | Stock Option (Right to Buy) Stock Option (Right to Buy) | ||
| PJT Partners Inc (Class A) | Mr. Paul J. Taubman | Director, Chairman and CEO | 30 Jul 2026 | 36,000 | 5,352,000 | - | - | Partnership Units of PJT Partners Holdings LP | ||
| Strata Critical Medical Inc (Class A) | Mr. Andrew C. Lauck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 35,260 | 170,902 | - | 0 | Class A common stock, $0.0001 par value per share | |
| GM | Mr. Grant Michael Dixton | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.40 per share. | 30 Jul 2026 | 35,056 | 94,992 (0%) | 0% | 88.4 | 3,098,950 | Common Stock |
| Heron Therapeutics Inc | Mr. Craig A. Collard | Director, Chief Executive Officer | 30 Jul 2026 | 34,789 | 347,886 | - | - | Restricted Stock Units | ||
| Heron Therapeutics Inc | Mr. Craig A. Collard | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2026 | 34,789 | 856,492 (0%) | 0% | - | Common Stock | |
| Strata Critical Medical Inc (Class A) | Mr. Amir M. Cohen | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.09 per share. | 30 Jul 2026 | 34,015 | 181,799 | - | 5.1 | 173,136 | Class A common stock, $0.0001 par value per share |
| Marathon Digital Holdings Inc | Mr. Salman H. Khan | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.82 per share. | 30 Jul 2026 | 33,569 | 1,636,571 (20%) | 0% | 11.8 | 396,786 | Common Stock |
| Intel | Mr. Nagasubramaniyan Chandrasekaran | EVP, CT & Ops Off, GM Foundry | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2026 | 33,007 | 238,859 (0%) | 0% | - | Common Stock | |
| Intel | Mr. Nagasubramaniyan Chandrasekaran | EVP, CT & Ops Off, GM Foundry | 30 Jul 2026 | 33,007 | 33,008 | - | - | Restricted Stock Units | ||
| Apnimed Inc | Mr. Michael B. Kelly | Chief Financial Officer | 30 Jul 2026 | 31,434 | 31,434 | - | - | Stock Option (Right to Buy) | ||
| Apnimed Inc | Mr. Michael B. Kelly | Chief Financial Officer | 30 Jul 2026 | 31,434 | 31,434 | - | - | Stock Option (Right to Buy) | ||
| Apnimed Inc | Mr. Michael B. Kelly | Chief Financial Officer | 30 Jul 2026 | 31,434 | 0 | - | - | Stock Option (Right to Buy) | ||
| Strata Critical Medical Inc (Class A) | Mr. Edward M. Philip | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 30,913 | 265,078 | - | 0 | Class A common stock, $0.0001 par value per share | |
| American Airlines Grp Inc | Mr. Stephen L. Johnson | Vice Chair | Sale of securities on an exchange or to another person at price $ 15.29 per share. | 30 Jul 2026 | 30,000 | 1,938,357 (0%) | 0% | 15.3 | 458,790 | Common Stock |
| American Airlines Grp Inc | Mr. Stephen L. Johnson | Vice Chair | Sale of securities on an exchange or to another person at price $ 15.26 per share. | 30 Jul 2026 | 30,000 | 1,968,357 (0%) | 0% | 15.3 | 457,878 | Common Stock |
| Performance Food Grp Co | Mr. George L. Holm | Director, See Remarks | 30 Jul 2026 | 29,131 | 0 | - | - | Options (Right to Buy) | ||
| Performance Food Grp Co | Mr. George L. Holm | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.57 per share. | 30 Jul 2026 | 29,131 | 1,650,683 (1%) | 0% | 26.6 | 774,011 | Common Stock |
| Richardson Electronics Ltd | Mr. Robert H. Kluge | Director | Sale of securities on an exchange or to another person at price $ 17.90 per share. | 30 Jul 2026 | 29,000 | 51,365 (0%) | 0% | 17.9 | 519,184 | Common Stock |
| Apnimed Inc | Mr. Dennis Patrick Molnar | President | 30 Jul 2026 | 28,539 | 0 | - | - | Stock Option (Right to Buy) | ||
| Apnimed Inc | Mr. Dennis Patrick Molnar | President | 30 Jul 2026 | 28,539 | 28,539 | - | - | Stock Option (Right to Buy) | ||
| Core Scientific Inc - Ordinary Shares - New | Mr. Mark W. Adams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 27,594 | 27,594 | - | 0 | Common Stock | |
| Performance Food Grp Co | Mr. George L. Holm | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 114.50 per share. | 30 Jul 2026 | 27,441 | 1,623,242 (1%) | 0% | 114.5 | 3,141,995 | Common Stock |
| Strata Critical Medical Inc (Class A) | Mr. Amir M. Cohen | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 27,420 | 215,814 | - | 0 | Class A common stock, $0.0001 par value per share | |
| Associated Banc-Corp. | Mr. Randall J. Erickson | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.20 per share. | 30 Jul 2026 | 26,480 | 75,022 (0%) | 0% | 25.2 | 667,296 | Common Stock $0.01 Par Value |
| Associated Banc-Corp. | Mr. Randall J. Erickson | Executive Vice President | 30 Jul 2026 | 26,480 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | ||
| Cue Biopharma Inc | Mr. James M. Ahlers | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 25,500 | 25,500 (0%) | 0% | 0 | Common Stock | |
| Motorsport Games Inc (Class A) | Mr. Stanley Beckley | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 25,000 | 25,000 | - | 0 | Class A Common Stock | |
| Identiv Inc | James Ousley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 23,810 | 309,266 (1%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | Mr. Warren G. Nighan, Jr | SVP Quality and Regulatory | Sale of securities on an exchange or to another person at price $ 14.72 per share. | 30 Jul 2026 | 23,370 | 64,745 (0%) | 0% | 14.7 | 344,006 | Common Stock |
| Inhibikase Therapeutics Inc | Mr. Dennis N. Berman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.26 per share. | 30 Jul 2026 | 21,854 | 21,854 | - | 1.3 | 27,536 | Common Stock |
| Inhibikase Therapeutics Inc | Mr. Dennis N. Berman | Director | 30 Jul 2026 | 21,854 | 0 | - | - | Stock Option (Right to Buy) | ||
| Rush Enterprises Inc (Class A) | Mr. Steven L. Keller | CFO & Treasurer | 30 Jul 2026 | 20,678 | 0 | - | - | Option (right to buy) | ||
| Rush Enterprises Inc (Class A) | Mr. Steven L. Keller | CFO & Treasurer | Sale of securities on an exchange or to another person at price $ 80.73 per share. | 30 Jul 2026 | 20,678 | 84,373 (0%) | 0% | 80.7 | 1,669,256 | Class A Common Stock |
| Rush Enterprises Inc (Class A) | Mr. Steven L. Keller | CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.06 per share. | 30 Jul 2026 | 20,678 | 105,051 (0%) | 0% | 15.1 | 311,411 | Class A Common Stock |
| Datadog Inc (Class A) | Mr. Amit Agarwal | Director | 30 Jul 2026 | 20,000 | 230,059 | - | - | Class B Common Stock | ||
| Datadog Inc (Class A) | Mr. Amit Agarwal | Director | 30 Jul 2026 | 20,000 | 21,640 (0%) | 0% | 0 | Class A Common Stock | ||
| PAMT Corp | Mr. Daniel C. Kleine | SVP of Fin., CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 20,000 | 21,785 (0%) | 0% | 0 | Common Stock | |
| Visa | Ms. Kelly Mahon Tullier | VICE CHAIR, CHF PPL & CORP AFF | Sale of securities on an exchange or to another person at price $ 364.81 per share. | 30 Jul 2026 | 19,991 | 49,662 (0%) | 0% | 364.8 | 7,292,941 | Class A Common Stock |
| Mobia Medical Inc | Dr. Myriam J. Curet, F.A.C.S.,M.D. | Director | 30 Jul 2026 | 19,740 | 19,740 | - | - | Stock Option | ||
| Identiv Inc | Mr. Miguel A. Lopez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 19,424 | 42,838 (0%) | 0% | 0 | - | |
| Identiv Inc | Ms. Laura Angelini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 18,797 | 68,476 (0%) | 0% | 0 | Common Stock | |
| Heartflow Inc | Mr. John C.M. Farquhar | Director, Chief Executive Officer | 30 Jul 2026 | 18,694 | 1,984,637 | - | - | Stock Option | ||
| Heartflow Inc | Mr. John C.M. Farquhar | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 30 Jul 2026 | 18,694 | 456,856 | - | 2.2 | 41,501 | Common Stock |
| Jersey Mikes Subs Inc | Ms. Michele Allen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 18,675 | 18,675 | - | - | Class B Common Stock | |
| Jersey Mikes Subs Inc | Ms. Michele Allen | Chief Financial Officer | 30 Jul 2026 | 18,675 | 18,675 | - | - | Common Units of Jersey Mikes HoldCo, LLC | ||
| Kyndryl Holdings Inc | Mr. Dominic J. Caruso | Director | Grant, award, or other acquisition of securities at price $ 13.45 per share. | 30 Jul 2026 | 17,844 | 77,930 | - | 13.5 | 240,002 | Common Stock |
| Kyndryl Holdings Inc | Ms. Jana R. Schreuder | Director | Grant, award, or other acquisition of securities at price $ 13.45 per share. | 30 Jul 2026 | 17,844 | 77,930 | - | 13.5 | 240,002 | Common Stock |
| Kyndryl Holdings Inc | Mr. John D. Harris, II | Director | Grant, award, or other acquisition of securities at price $ 13.45 per share. | 30 Jul 2026 | 17,844 | 77,986 | - | 13.5 | 240,002 | Common Stock |
| Kyndryl Holdings Inc | Dr. Shirley Ann Jackson, PhD | Director | Grant, award, or other acquisition of securities at price $ 13.45 per share. | 30 Jul 2026 | 17,844 | 84,656 | - | 13.5 | 240,002 | Common Stock |
| Kyndryl Holdings Inc | Mr. Rahul N. Merchant | Director | Grant, award, or other acquisition of securities at price $ 13.45 per share. | 30 Jul 2026 | 17,844 | 35,130 | - | 13.5 | 240,002 | Common Stock |
| Kyndryl Holdings Inc | Mr. Stephen Alan Michael Hester | Director | Grant, award, or other acquisition of securities at price $ 13.45 per share. | 30 Jul 2026 | 17,844 | 75,220 | - | 13.5 | 240,002 | Common Stock |
| Kyndryl Holdings Inc | Mr. Howard I. Ungerleider | Director | Grant, award, or other acquisition of securities at price $ 13.45 per share. | 30 Jul 2026 | 17,844 | 97,930 | - | 13.5 | 240,002 | Common Stock |
| Kyndryl Holdings Inc | Ms. Janina Kugel | Director | Grant, award, or other acquisition of securities at price $ 13.45 per share. | 30 Jul 2026 | 17,844 | 66,154 | - | 13.5 | 240,002 | Common Stock |
| Kyndryl Holdings Inc | Mr. Denis Machuel | Director | Grant, award, or other acquisition of securities at price $ 13.45 per share. | 30 Jul 2026 | 17,844 | 75,645 | - | 13.5 | 240,002 | Common Stock |
| Skywest Inc | Mr. Greg S. Wooley | EXEC VP OPERATIONS | Sale of securities on an exchange or to another person at price $ 108.55 per share. | 30 Jul 2026 | 17,726 | 53,323 (0%) | 0% | 108.6 | 1,924,173 | Common Stock |
| Identiv Inc | Dr. Richard E. Kuntz, M.D.,M.Sc. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 17,544 | 65,712 (0%) | 0% | 0 | Common Stock | |
| Cracker Barrel Old Country Store Inc | Mr. Doug Hisel | SVP, Store Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 17,519 | 21,960 (0%) | 0% | 0 | - | |
| SEACOR Marine Holdings Inc | Mr. Andrew H. Everett, II | Sr. VP, General Counsel & Secy | Sale of securities on an exchange or to another person at price $ 9.51 per share. | 30 Jul 2026 | 17,232 | 206,363 (0%) | 0% | 9.5 | 163,876 | Common Stock |
| Mobia Medical Inc | Dr. Myriam J. Curet, F.A.C.S.,M.D. | Director | 30 Jul 2026 | 15,960 | 15,960 | - | - | Stock Option | ||
| Identiv Inc | Mr. Gary Kremen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 15,664 | 318,226 (1%) | 0% | 0 | Common Stock | |
| Community Healthcare Trust Inc | Mr. David H. Dupuy | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 15,573 | 547,262 (2%) | 0% | 0 | Common Stock | |
| Corcept Therapeutics Inc | Mr. Atabak Mokari | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 114.96 per share. | 30 Jul 2026 | 15,477 | 59,595 (0%) | 0% | 115.0 | 1,779,237 | Common Stock |
| reAlpha Tech Corp | Mr. Thomas J. Kutzman, Jr | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 30 Jul 2026 | 15,121 | 115,919 | - | - | Common Stock | |
| Ionis Pharma Inc | Dr. Michael Hayden, M.D.,PhD | Director | Purchase of securities on an exchange or from another person at price $ 53.38 per share. | 30 Jul 2026 | 15,000 | 19,000 (0%) | 0% | 53.4 | 800,700 | Common Stock |
| SEACOR Marine Holdings Inc | Mr. Gregory S. Rossmiller | SVP & CAO | Sale of securities on an exchange or to another person at price $ 9.52 per share. | 30 Jul 2026 | 15,000 | 244,506 (1%) | 0% | 9.5 | 142,800 | Common Stock |
| Jersey Mikes Subs Inc | Ms. Stacy Peterson | President and COO | Purchase of securities on an exchange or from another person at price $ 23.00 per share. | 30 Jul 2026 | 15,000 | 15,000 | - | 23 | 345,000 | Class A Common Stock |
| Grocery Outlet Holding Corp | Ms. Carey F. Jaros | Director | Purchase of securities on an exchange or from another person at price $ 11.70 per share. | 30 Jul 2026 | 15,000 | 60,000 (0%) | 0% | 11.7 | 175,500 | Common Stock |
| Intel | Mr. Nagasubramaniyan Chandrasekaran | EVP, CT & Ops Off, GM Foundry | Payment of exercise price or tax liability using portion of securities received from the company at price $ 90.04 per share. | 30 Jul 2026 | 14,738 | 224,121 (0%) | 0% | 90.0 | 1,327,010 | Common Stock |
| Bridgewater Bancshares Inc | Ms. Mary Jayne Crocker | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.48 per share. | 30 Jul 2026 | 14,575 | 235,384 (0%) | 0% | 20.5 | 298,496 | Common Stock |
| Corcept Therapeutics Inc | Mr. Atabak Mokari | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 115.87 per share. | 30 Jul 2026 | 14,222 | 45,373 (0%) | 0% | 115.9 | 1,647,859 | Common Stock |
| Cytokinetics Inc | Mr. Andrew M. Callos | EVP, Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.26 per share. | 30 Jul 2026 | 14,000 | 72,555 (0%) | 0% | 23.3 | 325,640 | Common Stock |
| Cytokinetics Inc | Mr. Andrew M. Callos | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 79.88 per share. | 30 Jul 2026 | 14,000 | 58,555 (0%) | 0% | 79.9 | 1,118,320 | Common Stock |
| Cytokinetics Inc | Mr. Andrew M. Callos | EVP, Chief Commercial Officer | 30 Jul 2026 | 14,000 | 10,000 | - | - | Non-Qualified Stock Option (Right to Buy) | ||
| Strata Critical Medical Inc (Class A) | Mr. Scott. M Wunsch | CEO, Logistics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.09 per share. | 30 Jul 2026 | 13,992 | 668,754 | - | 5.1 | 71,219 | Class A common stock, $0.0001 par value per share |
| Heron Therapeutics Inc | Ms. Ira Duarte | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2026 | 13,535 | 277,381 (0%) | 0% | - | Common Stock | |
| Heron Therapeutics Inc | Ms. Ira Duarte | EVP, Chief Financial Officer | 30 Jul 2026 | 13,535 | 189,492 | - | - | Restricted Stock Units | ||
| Marathon Digital Holdings Inc | Mr. Zabi Nowaid | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.82 per share. | 30 Jul 2026 | 13,428 | 921,040 (11%) | 0% | 11.8 | 158,719 | Common Stock |
| Northwest Bancshares Inc | Mr. James M. Colestro | Chief Retail Lending Officer | Sale of securities on an exchange or to another person at price $ 15.77 per share. | 30 Jul 2026 | 13,274 | 37,011 (0%) | 0% | 15.8 | 209,331 | Northwest Bancshares, Inc. Common Stock |
| reAlpha Tech Corp | Mr. Dimitrios J. Angelis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 13,074 | 19,644 | - | 0 | Common Stock | |
| reAlpha Tech Corp | Mr. Prabhu Antony | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 13,074 | 14,584 | - | 0 | Common Stock | |
| reAlpha Tech Corp | Mr. Balaji Swaminathan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 13,074 | 19,644 | - | 0 | Common Stock | |
| Kestra Medical Tech Ltd | Mr. Brian Webster | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 23.92 per share. | 30 Jul 2026 | 13,017 | 527,115 | - | 23.9 | 311,424 | Common Shares |
| Burke & Herbert Fin Services Corp | Mr. Robert S. Tissue | EVP, Balance Sheet Strategy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.63 per share. | 30 Jul 2026 | 12,914 | 58,064 | - | 73.6 | 950,858 | Common Stock |
| SEACOR Marine Holdings Inc | Mr. Gregory S. Rossmiller | SVP & CAO | Sale of securities on an exchange or to another person at price $ 8.74 per share. | 30 Jul 2026 | 12,741 | 259,506 (1%) | 0% | 8.7 | 111,356 | Common Stock |
| Oceaneering Intl Inc | Mr. Earl F. Childress | SVP, Chief Commercial Ofc. | Sale of securities on an exchange or to another person at price $ 46.71 per share. | 30 Jul 2026 | 12,701 | 22,876 (0%) | 0% | 46.7 | 593,315 | Common Stock |
| Motorsport Games Inc (Class A) | Mr. Peter Hansen-Chambers | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 12,500 | 25,000 | - | 0 | Class A Common Stock | |
| Motorsport Games Inc (Class A) | Mr. Peter Hansen-Chambers | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 12,500 | 12,500 | - | 0 | Class A Common Stock | |
| Midera Food Processing Inc | Ms. Amy A. Campbell | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 12,463 | 12,463 | - | - | Common Stock | |
| Midera Food Processing Inc | Mr. Mark S. Bowie | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 12,463 | 12,463 | - | - | Common Stock | |
| Mobileye Global Inc (Class A) | Mr. Frank D. Yeary | Director | Purchase of securities on an exchange or from another person at price $ 7.98 per share. | 30 Jul 2026 | 12,360 | 12,360 | - | 8.0 | 98,633 | Class A Common Stock |
| Apnimed Inc | Mr. Dennis Patrick Molnar | President | 30 Jul 2026 | 12,231 | 0 | - | - | Stock Option (Right to Buy) | ||
| Apnimed Inc | Mr. Dennis Patrick Molnar | President | 30 Jul 2026 | 12,231 | 12,231 | - | - | Stock Option (Right to Buy) | ||
| Old National Bancorp | Mr. Chady M. AlAhmar | CEO, WEALTH MANAGEMENT | Sale of securities on an exchange or to another person at price $ 26.41 per share. | 30 Jul 2026 | 11,771 | 63,531 (0%) | 0% | 26.4 | 310,844 | Common Stock |
| Heron Therapeutics Inc | Dr. William P. Forbes, Pharm.D. | EVP, Chief Development Officer | 30 Jul 2026 | 11,769 | 164,776 | - | - | Restricted Stock Units | ||
| Heron Therapeutics Inc | Dr. William P. Forbes, Pharm.D. | EVP, Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2026 | 11,769 | 236,153 (0%) | 0% | - | Common Stock | |
| Heron Therapeutics Inc | Dr. William P. Forbes, Pharm.D. | EVP, Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2026 | 11,694 | 244,499 (0%) | 0% | - | Common Stock | |
| Heron Therapeutics Inc | Dr. William P. Forbes, Pharm.D. | EVP, Chief Development Officer | 30 Jul 2026 | 11,694 | 116,944 | - | - | Restricted Stock Units | ||
| Heron Therapeutics Inc | Ms. Ira Duarte | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2026 | 11,694 | 285,225 (0%) | 0% | - | Common Stock | |
| Heron Therapeutics Inc | Ms. Ira Duarte | EVP, Chief Financial Officer | 30 Jul 2026 | 11,694 | 116,944 | - | - | Restricted Stock Units | ||
| Globe Life | Mr. Thomas Peter Kalmbach | EVP & CFO | 30 Jul 2026 | 11,000 | 0 | - | - | Employee Stock Option (right to buy) | ||
| Globe Life | Mr. Thomas Peter Kalmbach | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 120.49 per share. | 30 Jul 2026 | 11,000 | 71,567 (0%) | 0% | 120.5 | 1,325,390 | Common Stock |
| Globe Life | Mr. Thomas Peter Kalmbach | EVP & CFO | Sale of securities on an exchange or to another person at price $ 179.30 per share. | 30 Jul 2026 | 10,720 | 60,847 (0%) | 0% | 179.3 | 1,922,066 | Common Stock |
| Community Healthcare Trust Inc | Mr. William G. Monroe, IV | Executive Vice President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 10,163 | 228,339 (1%) | 0% | 0 | Common Stock | |
| Globe Life | Mr. Thomas Peter Kalmbach | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 103.23 per share. | 30 Jul 2026 | 10,000 | 60,567 (0%) | 0% | 103.2 | 1,032,300 | Common Stock |
| Globe Life | Mr. Thomas Peter Kalmbach | EVP & CFO | 30 Jul 2026 | 10,000 | 0 | - | - | Employee Stock Option (Right to Buy) | ||
| Business First Bancshares Inc | Mr. George W Cummings, III | Director | Sale of securities on an exchange or to another person at price $ 31.50 per share. | 30 Jul 2026 | 10,000 | 221,180 (1%) | 0% | 31.5 | 315,000 | COMMON STOCK |
| Business First Bancshares Inc | Mr. George W Cummings, III | Director | Sale of securities on an exchange or to another person at price $ 32.08 per share. | 30 Jul 2026 | 10,000 | 231,180 (1%) | 0% | 32.1 | 320,800 | COMMON STOCK |
| HomeTrust Bancshares Inc | Ms. Laura C. Kendall | Director | 30 Jul 2026 | 10,000 | 0 | - | - | Stock Option | ||
| HomeTrust Bancshares Inc | Ms. Laura C. Kendall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.95 per share. | 30 Jul 2026 | 10,000 | 34,229 (0%) | 0% | 25.0 | 249,500 | Common Stock |
| HomeTrust Bancshares Inc | Ms. Laura C. Kendall | Director | Sale of securities on an exchange or to another person at price $ 51.13 per share. | 30 Jul 2026 | 10,000 | 24,229 (0%) | 0% | 51.1 | 511,348 | Common Stock |
| Richardson Electronics Ltd | Mr. Robert H. Kluge | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.87 per share. | 30 Jul 2026 | 10,000 | 61,365 (0%) | 0% | 5.9 | 58,700 | Common Stock |
| Richardson Electronics Ltd | Mr. Robert H. Kluge | Director | 30 Jul 2026 | 10,000 | 0 | - | - | Employee Stock Option (Right to Buy) | ||
| Jersey Mikes Subs Inc | Mr. Andrew G. Skehan | See Remarks | Purchase of securities on an exchange or from another person at price $ 23.00 per share. | 30 Jul 2026 | 10,000 | 10,000 | - | 23 | 230,000 | Class A Common Stock |
| Jersey Mikes Subs Inc | Ms. Michele Allen | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 23.00 per share. | 30 Jul 2026 | 10,000 | 10,043 | - | 23 | 230,000 | Class A Common Stock |
| Heartflow Inc | Mr. John C.M. Farquhar | Director, Chief Executive Officer | 30 Jul 2026 | 9,737 | 182,043 | - | - | Stock Option | ||
| Heartflow Inc | Mr. John C.M. Farquhar | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.58 per share. | 30 Jul 2026 | 9,737 | 466,593 | - | 9.6 | 93,280 | Common Stock |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | 30 Jul 2026 | 9,500 | 236,910 | - | - | Stock Option | ||
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share. | 30 Jul 2026 | 9,500 | 333,943 (0%) | 0% | 135.4 | 1,286,490 | Common Stock |
| Entergy | Mr. Jason Chapman | SVP Chief Tech & Bus Servs Off | Sale of securities on an exchange or to another person at price $ 109.06 per share. | 30 Jul 2026 | 9,447 | 17,176 (0%) | 0% | 109.1 | 1,030,290 | Common Stock |
| Merchants Bancorp | Ms. Julia Kaercher | Director | Sale of securities on an exchange or to another person at price $ 55.20 per share. | 30 Jul 2026 | 9,000 | 727,103 (2%) | 0% | 55.2 | 496,800 | Common Stock |
| Merchants Bancorp | Mr. Michael F. Petrie | Director, Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 55.20 per share. | 30 Jul 2026 | 9,000 | 727,013 (2%) | 0% | 55.2 | 496,800 | Common Stock |
| Corcept Therapeutics Inc | Mr. Atabak Mokari | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 106.96 per share. | 30 Jul 2026 | 8,956 | 82,974 (0%) | 0% | 107.0 | 957,892 | Common Stock |
| Kestra Medical Tech Ltd | Mr. Brian Webster | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 22.60 per share. | 30 Jul 2026 | 8,948 | 540,132 | - | 22.6 | 202,260 | Common Shares |
| Kestra Medical Tech Ltd | Mr. Vaseem Mahboob | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 22.61 per share. | 30 Jul 2026 | 8,817 | 99,282 | - | 22.6 | 199,344 | Common Shares |
| Kestra Medical Tech Ltd | Ms. Traci S. Umberger | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 22.60 per share. | 30 Jul 2026 | 8,752 | 206,995 | - | 22.6 | 197,837 | Common Shares |
| Burke & Herbert Fin Services Corp | Mr. Robert S. Tissue | EVP, Balance Sheet Strategy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.33 per share. | 30 Jul 2026 | 8,684 | 62,542 | - | 43.3 | 376,278 | Common Stock |
| Burke & Herbert Fin Services Corp | Mr. Robert S. Tissue | EVP, Balance Sheet Strategy | 30 Jul 2026 | 8,684 | 0 | - | - | Stock Settled Appreciation Rights | ||
| Community Healthcare Trust Inc | Ms. Leigh Ann Stach | Executive Vice President & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 8,589 | 466,128 (2%) | 0% | 0 | Common Stock | |
| Burke & Herbert Fin Services Corp | Mr. Robert S. Tissue | EVP, Balance Sheet Strategy | 30 Jul 2026 | 8,436 | 0 | - | - | Stock Settled Appreciation Rights | ||
| Burke & Herbert Fin Services Corp | Mr. Robert S. Tissue | EVP, Balance Sheet Strategy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 52.29 per share. | 30 Jul 2026 | 8,436 | 70,978 | - | 52.3 | 441,118 | Common Stock |
| Sono-Tek Corp | Mr. Stephen J. Bagley, C.P.A. | CFO | Sale of securities on an exchange or to another person at price $ 5.13 per share. | 30 Jul 2026 | 8,346 | 21,254 | - | 5.1 | 42,815 | SonoTek Common Stock |
| Corcept Therapeutics Inc | Mr. Atabak Mokari | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 117.93 per share. | 30 Jul 2026 | 8,267 | 30,017 (0%) | 0% | 117.9 | 974,951 | Common Stock |
| Corcept Therapeutics Inc | Mr. Atabak Mokari | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 119.95 per share. | 30 Jul 2026 | 8,103 | 17,131 (0%) | 0% | 119.9 | 971,939 | Common Stock |
| Fulton Fin Corp | Mr. E. Philip Wenger | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Jul 2026 | 8,000 | 575,918 (0%) | 0% | 0 | $2.50 par value Common Stock | |
| Kestra Medical Tech Ltd | Mr. Brian Webster | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 22.72 per share. | 30 Jul 2026 | 7,857 | 549,080 | - | 22.7 | 178,531 | Common Shares |
| PulteGroup | Mr. Bryce Blair | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Jul 2026 | 7,639 | 16,800 (0%) | 0% | 0 | Common Stock | |
| PulteGroup | Mr. Bryce Blair | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Jul 2026 | 7,639 | 126,732 (0%) | 0% | 0 | Common Stock | |
| Kestra Medical Tech Ltd | Ms. Traci S. Umberger | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 23.86 per share. | 30 Jul 2026 | 7,590 | 199,405 | - | 23.9 | 181,062 | Common Shares |
| Freeport-McMoRan Inc | Mr. Stephen T. Higgins | EVP & CAO | Sale of securities on an exchange or to another person at price $ 63.00 per share. | 30 Jul 2026 | 7,550 | 68,895 (0%) | 0% | 63 | 475,650 | Common Stock |
| Corcept Therapeutics Inc | Mr. Atabak Mokari | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 116.96 per share. | 30 Jul 2026 | 7,089 | 38,284 (0%) | 0% | 117.0 | 829,102 | Common Stock |
| Datadog Inc (Class A) | Mr. Amit Agarwal | Director | Sale of securities on an exchange or to another person at price $ 267.16 per share. | 30 Jul 2026 | 7,084 | 4,940 (0%) | 0% | 267.2 | 1,892,542 | Class A Common Stock |
| LiveWire Grp Inc | Dr. Kjell Gruner, PhD | Director | Sale of securities on an exchange or to another person at price $ 1.98 per share. | 30 Jul 2026 | 7,070 | 202,318 | - | 2.0 | 14,000 | Common Stock |
| Provident Financial Holdings | Mr. Matthew E. Webb | Director | 30 Jul 2026 | 7,000 | 17,000 | - | - | Option to Purchase Common Stock | ||
| Provident Financial Holdings | Mr. Matthew E. Webb | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.09 per share. | 30 Jul 2026 | 7,000 | 8,000 (0%) | 0% | 12.1 | 84,630 | Common Stock, PAR Value $0.01 |
| Datadog Inc (Class A) | Mr. Amit Agarwal | Director | Sale of securities on an exchange or to another person at price $ 266.32 per share. | 30 Jul 2026 | 6,969 | 12,024 (0%) | 0% | 266.3 | 1,856,007 | Class A Common Stock |
| Stock Yards Bancorp Inc | Ms. Laura L. Wells | Director | Sale of securities on an exchange or to another person at price $ 86.29 per share. | 30 Jul 2026 | 6,823 | 9,580 (0%) | 0% | 86.3 | 588,757 | Common Stock |
| Northwest Bancshares Inc | Mr. James M. Colestro | Chief Retail Lending Officer | 30 Jul 2026 | 6,528 | 0 | - | - | Stock Options (Right to Buy) | ||
| Northwest Bancshares Inc | Mr. James M. Colestro | Chief Retail Lending Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.68 per share. | 30 Jul 2026 | 6,528 | 50,285 (0%) | 0% | 13.7 | 89,303 | Northwest Bancshares, Inc. Common Stock |
| Block Inc (Class A) | Mr. Anthony Eisen | Director | Sale of securities on an exchange or to another person at price $ 81.52 per share. | 30 Jul 2026 | 6,000 | 1,613,672 (0%) | 0% | 81.5 | 489,120 | Class A Common Stock |
| Block Inc (Class A) | Mr. Anthony Eisen | Director | Sale of securities on an exchange or to another person at price $ 81.17 per share. | 30 Jul 2026 | 6,000 | 1,625,672 (0%) | 0% | 81.2 | 487,020 | Class A Common Stock |
| Block Inc (Class A) | Mr. Anthony Eisen | Director | Sale of securities on an exchange or to another person at price $ 82.27 per share. | 30 Jul 2026 | 6,000 | 1,619,672 (0%) | 0% | 82.3 | 493,620 | Class A Common Stock |
| Kestra Medical Tech Ltd | Ms. Traci S. Umberger | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 22.74 per share. | 30 Jul 2026 | 5,887 | 215,747 | - | 22.7 | 133,892 | Common Shares |
| Uranium Royalty Corp | Mr. Scott Melbye | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.13 per share. | 30 Jul 2026 | 5,850 | 615,898 | - | 3.1 | 18,309 | Common Stock |
| Maravai LifeSciences Holdings Inc (Class A) | Mr. Rajesh J. Asarpota | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.59 per share. | 30 Jul 2026 | 5,465 | 428,951 | - | 6.6 | 36,014 | Class A Common Stock |
| Kestra Medical Tech Ltd | Mr. Vaseem Mahboob | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 23.80 per share. | 30 Jul 2026 | 5,391 | 93,891 | - | 23.8 | 128,312 | Common Shares |
| Solstice Advanced Materials | Ms. Tina Pierce | SVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2026 | 5,291 | 14,045 | - | - | Common Stock | |
| Solstice Advanced Materials | Ms. Tina Pierce | SVP and CFO | 30 Jul 2026 | 5,291 | 0 | - | - | Restricted Stock Units | ||
| Entergy | Mr. Jason Chapman | SVP Chief Tech & Bus Servs Off | 30 Jul 2026 | 5,140 | 5,140 | - | - | Employee Stock Option (Right to Buy) | ||
| Entergy | Mr. Jason Chapman | SVP Chief Tech & Bus Servs Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 49.54 per share. | 30 Jul 2026 | 5,140 | 24,050 (0%) | 0% | 49.5 | 254,636 | Common Stock |
| Manhattan Associates Inc | Mr. James Stewart Gantt | EVP, Professional Services | Sale of securities on an exchange or to another person at price $ 195.53 per share. | 30 Jul 2026 | 5,139 | 55,676 (0%) | 0% | 195.5 | 1,004,831 | Common Stock |
| Aehr Test Systems | Mr. Howard T. Slayen | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Jul 2026 | 5,000 | 166,367 (0%) | 0% | 0 | Common Stock | |
| Commerce Bancshares Inc | Mr. Robert S. Holmes | Executive Vice President | Sale of securities on an exchange or to another person at price $ 60.20 per share. | 30 Jul 2026 | 5,000 | 55,962 (0%) | 0% | 60.2 | 301,000 | Common Stock |
| Ionis Pharma Inc | Dr. Michael Hayden, M.D.,PhD | Director | Purchase of securities on an exchange or from another person at price $ 51.60 per share. | 30 Jul 2026 | 5,000 | 24,000 (0%) | 0% | 51.6 | 258,000 | Common Stock |
| Richardson Electronics Ltd | Mr. Robert H. Kluge | Director | 30 Jul 2026 | 5,000 | 0 | - | - | Employee Stock Option (Right to Buy) | ||
| Richardson Electronics Ltd | Mr. Robert H. Kluge | Director | 30 Jul 2026 | 5,000 | 0 | - | - | Employee Stock Option (Right to Buy) | ||
| Richardson Electronics Ltd | Mr. Robert H. Kluge | Director | 30 Jul 2026 | 5,000 | 0 | - | - | Employee Stock Option (Right to Buy) | ||
| Richardson Electronics Ltd | Mr. Robert H. Kluge | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.26 per share. | 30 Jul 2026 | 5,000 | 76,365 (0%) | 0% | 4.3 | 21,300 | Common Stock |
| Richardson Electronics Ltd | Mr. Robert H. Kluge | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.61 per share. | 30 Jul 2026 | 5,000 | 71,365 (0%) | 0% | 5.6 | 28,050 | Common Stock |
| Richardson Electronics Ltd | Mr. Robert H. Kluge | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.10 per share. | 30 Jul 2026 | 5,000 | 66,365 (0%) | 0% | 9.1 | 45,500 | Common Stock |
| Groupon Inc | Ms. Kyle Netzly | Chief Accounting Officer | 30 Jul 2026 | 4,950 | 55,050 | - | - | Performance Share Units | ||
| Groupon Inc | Ms. Kyle Netzly | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2026 | 4,950 | 35,917 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 524.88 per share. | 30 Jul 2026 | 4,846 | 326,967 (0%) | 0% | 524.9 | 2,543,589 | Common Stock |
| Globe Life | Mr. Thomas Peter Kalmbach | EVP & CFO | Sale of securities on an exchange or to another person at price $ 180.08 per share. | 30 Jul 2026 | 4,840 | 56,007 (0%) | 0% | 180.1 | 871,578 | Common Stock |
| Corcept Therapeutics Inc | Mr. Atabak Mokari | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 118.73 per share. | 30 Jul 2026 | 4,783 | 25,234 (0%) | 0% | 118.7 | 567,908 | Common Stock |
| Corcept Therapeutics Inc | Mr. Atabak Mokari | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 113.18 per share. | 30 Jul 2026 | 4,700 | 75,072 (0%) | 0% | 113.2 | 531,941 | Common Stock |
| Northwest Bancshares Inc | Mr. James M. Colestro | Chief Retail Lending Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.71 per share. | 30 Jul 2026 | 4,568 | 43,757 (0%) | 0% | 9.7 | 44,355 | Northwest Bancshares, Inc. Common Stock |
| Northwest Bancshares Inc | Mr. James M. Colestro | Chief Retail Lending Officer | 30 Jul 2026 | 4,568 | 0 | - | - | Stock Options (Right to Buy) | ||
| City Holding Co. | Mr. Charles R. Hageboeck, PhD | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 144.96 per share. | 30 Jul 2026 | 4,485 | 43,998 (0%) | 0% | 145.0 | 650,129 | Common Stock |
| Solstice Advanced Materials | Mr. Brian Scott Rudick | SVP, Gen. Counsel and Corp Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2026 | 4,234 | 11,075 | - | - | Common Stock | |
| Solstice Advanced Materials | Mr. Brian Scott Rudick | SVP, Gen. Counsel and Corp Sec | 30 Jul 2026 | 4,234 | 0 | - | - | Restricted Stock Units | ||
| Business First Bancshares Inc | Mr. Keith John Mansfield | EVP&COO of b1Bank | Sale of securities on an exchange or to another person at price $ 32.08 per share. | 30 Jul 2026 | 4,200 | 77,139 (0%) | 0% | 32.1 | 134,736 | COMMON STOCK |
| Corcept Therapeutics Inc | Mr. Atabak Mokari | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 105.54 per share. | 30 Jul 2026 | 4,200 | 91,930 (0%) | 0% | 105.5 | 443,248 | Common Stock |
| Airbnb | Mr. Nathan Blecharczyk | Director, Chief Strategy Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Jul 2026 | 4,077 | 12,370 | - | 0 | Class A Common Stock | |
| AMREP Corp | Ms. Adrienne M. Uleau | CFO and VP | Sale of securities on an exchange or to another person at price $ 23.49 per share. | 30 Jul 2026 | 4,000 | 6,574 (0%) | 0% | 23.5 | 93,960 | Common Stock |
| Atricure Inc | Mr. Michael H. Carrel | Director, President, CEO, & Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Jul 2026 | 4,000 | 774,434 (1%) | 0% | 0 | Common Stock | |
| Richardson Electronics Ltd | Mr. Robert H. Kluge | Director | 30 Jul 2026 | 4,000 | 1,000 | - | - | Employee Stock Option (Right to Buy) | ||
| Richardson Electronics Ltd | Mr. Robert H. Kluge | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.66 per share. | 30 Jul 2026 | 4,000 | 80,365 (0%) | 0% | 7.7 | 30,640 | Common Stock |
| Uranium Royalty Corp | Mr. Scott Melbye | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.12 per share. | 30 Jul 2026 | 4,000 | 606,048 | - | 3.1 | 12,480 | Common Stock |
| Uranium Royalty Corp | Mr. Scott Melbye | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.12 per share. | 30 Jul 2026 | 4,000 | 610,048 | - | 3.1 | 12,500 | Common Stock |
| SoundHound AI Inc (Class A) | Mr. Larry Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 4,000 | 116,631 | - | 0 | Class A Common Stock | |
| SoundHound AI Inc (Class A) | Dr. Eric R. Ball, PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 4,000 | 153,500 | - | 0 | Class A Common Stock | |
| SoundHound AI Inc (Class A) | Ms. Diana Sroka | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 4,000 | 174,614 | - | 0 | Class A Common Stock | |
| Kestra Medical Tech Ltd | Mr. Vaseem Mahboob | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 22.75 per share. | 30 Jul 2026 | 3,980 | 108,099 | - | 22.8 | 90,561 | Common Shares |
| Ecolab | Mr. Scott D. Kirkland | CHIEF FINANCIAL OFFICER | 30 Jul 2026 | 3,972 | 0 | - | - | Employee Stock Option (Right to Buy) | ||
| Ecolab | Mr. Scott D. Kirkland | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 117.73 per share. | 30 Jul 2026 | 3,972 | 20,881 (0%) | 0% | 117.7 | 467,624 | Common Stock |
| Nucor | Mr. Stephen D. Laxton | President and COO | Sale of securities on an exchange or to another person at price $ 256.96 per share. | 30 Jul 2026 | 3,968 | 77,866 (0%) | 0% | 257.0 | 1,019,617 | Common Stock |
| Heron Therapeutics Inc | Ms. Ira Duarte | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.50 per share. | 30 Jul 2026 | 3,850 | 273,531 (0%) | 0% | 0.5 | 1,925 | Common Stock |
| Nurix Therapeutics Inc | Dr. Gwenn Hansen, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 23.38 per share. | 30 Jul 2026 | 3,847 | 121,338 | - | 23.4 | 89,954 | Common Stock |
| Nurix Therapeutics Inc | Dr. Christine Ring, J.D.,PhD | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 23.38 per share. | 30 Jul 2026 | 3,847 | 19,912 | - | 23.4 | 89,954 | Common Stock |
| Midera Food Processing Inc | Ms. Cathy L. McCarthy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 3,802 | 15,391 | - | - | Common Stock | |
| Midera Food Processing Inc | Mr. Robert A. Nerbonne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 3,802 | 9,825 | - | - | Common Stock | |
| Heritage Fin Corp | Ms. Kelli Ann Wilson | EVP Chief Banking Officer | Sale of securities on an exchange or to another person at price $ 29.69 per share. | 30 Jul 2026 | 3,778 | 3,099 (0%) | 0% | 29.7 | 112,178 | Common Stock |
| Nurix Therapeutics Inc | Dr. Gwenn Hansen, PhD | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2026 | 3,750 | 118,755 | - | 0 | Common Stock | |
| Nurix Therapeutics Inc | Dr. Gwenn Hansen, PhD | Chief Scientific Officer | 30 Jul 2026 | 3,750 | 11,250 | - | - | Restricted Stock Units | ||
| Nurix Therapeutics Inc | Dr. Christine Ring, J.D.,PhD | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2026 | 3,750 | 17,329 | - | 0 | Common Stock | |
| Nurix Therapeutics Inc | Dr. Christine Ring, J.D.,PhD | Chief Legal Officer | 30 Jul 2026 | 3,750 | 11,250 | - | - | Restricted Stock Units | ||
| Nurix Therapeutics Inc | Mr. Hans van Houte | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2026 | 3,750 | 41,342 | - | 0 | Common Stock | |
| Nurix Therapeutics Inc | Mr. Hans van Houte | Chief Financial Officer | 30 Jul 2026 | 3,750 | 11,250 | - | - | Restricted Stock Units | ||
| Midera Food Processing Inc | Mr. Timothy J. Fitzgerald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 3,615 | 335,791 | - | - | Common Stock | |
| Midera Food Processing Inc | Ms. Janet H. Zelenka | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 3,615 | 4,862 | - | - | Common Stock | |
| Midera Food Processing Inc | Mr. James T. Glerum, Jr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 3,615 | 4,239 | - | - | Common Stock | |
| Midera Food Processing Inc | Mr. Carlos A. Fernandez Villena | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 3,615 | 4,239 | - | - | Common Stock | |
| Midera Food Processing Inc | Mr. Brian M. Jacoby | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 3,615 | 4,239 | - | - | Common Stock | |
| Nurix Therapeutics Inc | Dr. Gwenn Hansen, PhD | Chief Scientific Officer | 30 Jul 2026 | 3,572 | 39,303 | - | - | Restricted Stock Units | ||
| Nurix Therapeutics Inc | Dr. Gwenn Hansen, PhD | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2026 | 3,572 | 125,185 | - | 0 | Common Stock | |
| Nurix Therapeutics Inc | Dr. Christine Ring, J.D.,PhD | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2026 | 3,572 | 23,759 | - | 0 | Common Stock | |
| Nurix Therapeutics Inc | Dr. Christine Ring, J.D.,PhD | Chief Legal Officer | 30 Jul 2026 | 3,572 | 39,303 | - | - | Restricted Stock Units | ||
| Nurix Therapeutics Inc | Mr. Hans van Houte | Chief Financial Officer | 30 Jul 2026 | 3,572 | 39,303 | - | - | Restricted Stock Units | ||
| Nurix Therapeutics Inc | Mr. Hans van Houte | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2026 | 3,572 | 47,772 | - | 0 | Common Stock | |
| Accenture (Class A) | Mr. Joel Unruch | General Counsel/Corp Secretary | Sale of securities on an exchange or to another person at price $ 162.29 per share. | 30 Jul 2026 | 3,555 | 23,305 (0%) | 0% | 162.3 | 576,958 | Class A ordinary shares |
| Cheesecake Factory Inc | Ms. Ashley Hanscom | PRINCIPAL ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 100.00 per share. | 30 Jul 2026 | 3,500 | 7,541 (0%) | 0% | 100 | 350,000 | Common Stock |
| Popular Inc | Ms. Maria Luisa Ferre Rangel | Director | Sale of securities on an exchange or to another person at price $ 175.42 per share. | 30 Jul 2026 | 3,385 | 10,156 (0%) | 0% | 175.4 | 593,797 | Common Stock Par Value $0.01 per share |
| Ecolab | Mr. Scott D. Kirkland | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 276.96 per share. | 30 Jul 2026 | 3,357 | 17,524 (0%) | 0% | 277.0 | 929,755 | Common Stock |
| Heron Therapeutics Inc | Dr. William P. Forbes, Pharm.D. | EVP, Chief Development Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.50 per share. | 30 Jul 2026 | 3,348 | 232,805 (0%) | 0% | 0.5 | 1,674 | Common Stock |
| Heron Therapeutics Inc | Dr. William P. Forbes, Pharm.D. | EVP, Chief Development Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.50 per share. | 30 Jul 2026 | 3,326 | 241,173 (0%) | 0% | 0.5 | 1,663 | Common Stock |
| Heron Therapeutics Inc | Ms. Ira Duarte | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.50 per share. | 30 Jul 2026 | 3,326 | 281,899 (0%) | 0% | 0.5 | 1,663 | Common Stock |
| Jersey Mikes Subs Inc | Ms. Betsy J. Mercado | Chief People Officer | Purchase of securities on an exchange or from another person at price $ 23.00 per share. | 30 Jul 2026 | 3,265 | 3,265 | - | 23 | 75,095 | Class A Common Stock |
| AMKOR Tech Inc | Mr. Kevin Engel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 47.00 per share. | 30 Jul 2026 | 3,221 | 9,666 (0%) | 0% | 47 | 151,387 | Common Stock |
| Hasbro | Mr. John Hight | President, WOTC | Sale of securities on an exchange or to another person at price $ 93.71 per share. | 30 Jul 2026 | 3,186 | 67,557 (0%) | 0% | 93.7 | 298,551 | Common Stock (Par Value $.50 per share) |
| Solstice Advanced Materials | Mr. Jeffrey Harrison Dormo | SVP, Ref. and App. Solutions | 30 Jul 2026 | 3,176 | 0 | - | - | Restricted Stock Units | ||
| Solstice Advanced Materials | Mr. Jeffrey Harrison Dormo | SVP, Ref. and App. Solutions | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2026 | 3,176 | 6,877 | - | - | Common Stock | |
| Popular Inc | Ms. Maria Luisa Ferre Rangel | Director | Sale of securities on an exchange or to another person at price $ 173.79 per share. | 30 Jul 2026 | 3,076 | 34,400 (0%) | 0% | 173.8 | 534,566 | Common Stock Par Value $0.01 per share |
| Esquire Fin Holdings Inc | Mr. Robert J. Mitzman | Director | Sale of securities on an exchange or to another person at price $ 129.60 per share. | 30 Jul 2026 | 3,000 | 139,679 (1%) | 0% | 129.6 | 388,792 | Common Stock |
| Oceaneering Intl Inc | Mr. M. Kevin Mcevoy | Director | Sale of securities on an exchange or to another person at price $ 47.92 per share. | 30 Jul 2026 | 3,000 | 134,133 (0%) | 0% | 47.9 | 143,775 | Common Stock |
| Rocky Brands Inc | Mr. G. Courtney Haning | Director | Sale of securities on an exchange or to another person at price $ 49.06 per share. | 30 Jul 2026 | 3,000 | 19,750 (0%) | 0% | 49.1 | 147,180 | Common Stock, without par value |
| Rocky Brands Inc | Mr. G. Courtney Haning | Director | 30 Jul 2026 | 3,000 | 0 | - | - | Stock Option (right to buy) | ||
| Rocky Brands Inc | Mr. G. Courtney Haning | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.80 per share. | 30 Jul 2026 | 3,000 | 22,750 (0%) | 0% | 39.8 | 119,400 | Common Stock, without par value |
| Jetblue Airways Corp | Ms. Ursula Hurley | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.00 per share. | 30 Jul 2026 | 2,977 | 285,375 (0%) | 0% | 6 | 17,862 | Common Stock |
| Nurix Therapeutics Inc | Dr. Gwenn Hansen, PhD | Chief Scientific Officer | 30 Jul 2026 | 2,858 | 20,009 | - | - | Restricted Stock Units | ||
| Nurix Therapeutics Inc | Dr. Gwenn Hansen, PhD | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2026 | 2,858 | 121,613 | - | 0 | Common Stock | |
| Nurix Therapeutics Inc | Dr. Christine Ring, J.D.,PhD | Chief Legal Officer | 30 Jul 2026 | 2,858 | 20,009 | - | - | Restricted Stock Units | ||
| Nurix Therapeutics Inc | Dr. Christine Ring, J.D.,PhD | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2026 | 2,858 | 20,187 | - | 0 | Common Stock | |
| Nurix Therapeutics Inc | Mr. Hans van Houte | Chief Financial Officer | 30 Jul 2026 | 2,858 | 20,009 | - | - | Restricted Stock Units | ||
| Nurix Therapeutics Inc | Mr. Hans van Houte | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2026 | 2,858 | 44,200 | - | 0 | Common Stock | |
| Nurix Therapeutics Inc | Mr. Hans van Houte | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 23.38 per share. | 30 Jul 2026 | 2,845 | 44,927 | - | 23.4 | 66,524 | Common Stock |
| Globe Life | Mr. Thomas Peter Kalmbach | EVP & CFO | Sale of securities on an exchange or to another person at price $ 181.82 per share. | 30 Jul 2026 | 2,790 | 50,567 (0%) | 0% | 181.8 | 507,264 | Common Stock |
| Heartflow Inc | Mr. John C.M. Farquhar | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.33 per share. | 30 Jul 2026 | 2,789 | 438,162 | - | 8.3 | 23,232 | Common Stock |
| Heartflow Inc | Mr. John C.M. Farquhar | Director, Chief Executive Officer | 30 Jul 2026 | 2,789 | 65,703 | - | - | Stock Option | ||
| Accenture (Class A) | Mr. Joel Unruch | General Counsel/Corp Secretary | Sale of securities on an exchange or to another person at price $ 164.44 per share. | 30 Jul 2026 | 2,772 | 17,964 (0%) | 0% | 164.4 | 455,830 | Class A ordinary shares |
| Crowdstrike (Class A) | Mr. George R. Kurtz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 181.27 per share. | 30 Jul 2026 | 2,758 | 8,099,564 (19%) | 0% | 181.3 | 499,943 | Class A common stock |
| Crowdstrike (Class A) | Mr. George R. Kurtz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 190.88 per share. | 30 Jul 2026 | 2,685 | 8,083,597 (19%) | 0% | 190.9 | 512,513 | Class A common stock |
| Solstice Advanced Materials | Ms. Tina Pierce | SVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.65 per share. | 30 Jul 2026 | 2,651 | 11,394 | - | 58.6 | 155,481 | Common Stock |
| Globe Life | Mr. Thomas Peter Kalmbach | EVP & CFO | Sale of securities on an exchange or to another person at price $ 181.23 per share. | 30 Jul 2026 | 2,650 | 53,357 (0%) | 0% | 181.2 | 480,255 | Common Stock |
| Entergy | Mr. Jason Chapman | SVP Chief Tech & Bus Servs Off | 30 Jul 2026 | 2,573 | 5,146 | - | - | Employee Stock Option (Right to Buy) | ||
| Entergy | Mr. Jason Chapman | SVP Chief Tech & Bus Servs Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 82.79 per share. | 30 Jul 2026 | 2,573 | 26,623 (0%) | 0% | 82.8 | 213,019 | Common Stock |
| Accenture (Class A) | Mr. Joel Unruch | General Counsel/Corp Secretary | Sale of securities on an exchange or to another person at price $ 163.27 per share. | 30 Jul 2026 | 2,569 | 20,736 (0%) | 0% | 163.3 | 419,443 | Class A ordinary shares |
| Eagle Materials Inc | Ms. Margot Lebenberg Carter | Director | Sale of securities on an exchange or to another person at price $ 203.57 per share. | 30 Jul 2026 | 2,517 | 8,977 (0%) | 0% | 203.6 | 512,390 | Common Stock |
| Carter Bankshares Inc | Mr. Bradford N. Langs | PRESIDENT, CHIEF STRATEGY OFCR | Sale of securities on an exchange or to another person at price $ 34.54 per share. | 30 Jul 2026 | 2,500 | 33,242 | - | 34.5 | 86,340 | Common Stock |
| Vericel Corp | Mr. Jonathan D. Siegal | Principal Accounting Officer | 30 Jul 2026 | 2,500 | 4,000 | - | - | Stock Option (Right to Buy) | ||
| Vericel Corp | Mr. Jonathan D. Siegal | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 48.90 per share. | 30 Jul 2026 | 2,500 | 1,078 (0%) | 0% | 48.9 | 122,250 | Common Stock |
| Vericel Corp | Mr. Jonathan D. Siegal | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.82 per share. | 30 Jul 2026 | 2,500 | 3,578 (0%) | 0% | 29.8 | 74,550 | Common Stock |
| Midera Food Processing Inc | Mr. Robert A. Nerbonne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 2,493 | 6,023 | - | - | Common Stock | |
| Crowdstrike (Class A) | Mr. George R. Kurtz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 182.16 per share. | 30 Jul 2026 | 2,487 | 8,097,077 (19%) | 0% | 182.2 | 453,032 | Class A common stock |
| Nucor | Mr. Stephen D. Laxton | President and COO | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Jul 2026 | 2,409 | 81,834 (0%) | 0% | 0 | Common Stock | |
| Rush Enterprises Inc (Class A) | Mr. Michael L Goldstone | SVP, GC and Corp. Sec. | Sale of securities on an exchange or to another person at price $ 81.05 per share. | 30 Jul 2026 | 2,400 | 12,590 (0%) | 0% | 81.0 | 194,512 | Class A Common Stock |
| Rush Enterprises Inc (Class A) | Mr. Michael L Goldstone | SVP, GC and Corp. Sec. | 30 Jul 2026 | 2,400 | 2,100 | - | - | Option (right to buy) | ||
| Rush Enterprises Inc (Class A) | Mr. Michael L Goldstone | SVP, GC and Corp. Sec. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.06 per share. | 30 Jul 2026 | 2,400 | 14,990 (0%) | 0% | 15.1 | 36,144 | Class A Common Stock |
| Corcept Therapeutics Inc | Mr. Atabak Mokari | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 110.03 per share. | 30 Jul 2026 | 2,202 | 80,372 (0%) | 0% | 110.0 | 242,282 | Common Stock |
| Northwest Bancshares Inc | Mr. James M. Colestro | Chief Retail Lending Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.57 per share. | 30 Jul 2026 | 2,178 | 39,189 (0%) | 0% | 15.6 | 33,911 | Northwest Bancshares, Inc. Common Stock |
| Northwest Bancshares Inc | Mr. James M. Colestro | Chief Retail Lending Officer | 30 Jul 2026 | 2,178 | 0 | - | - | Stock Options (Right to Buy) | ||
| Hayward Holdings Inc | Mr. Stephen J. Felice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 2,152 | 366,485 | - | 0 | Common Stock | |
| Amalgamated Fin Corp | Ms. Maryann Bruce | Director | Sale of securities on an exchange or to another person at price $ 49.55 per share. | 30 Jul 2026 | 2,138 | 17,804 (0%) | 0% | 49.6 | 105,943 | Common Stock |
| Solstice Advanced Materials | Mr. Brian Scott Rudick | SVP, Gen. Counsel and Corp Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.65 per share. | 30 Jul 2026 | 2,122 | 8,953 | - | 58.6 | 124,455 | Common Stock |
| Rush Enterprises Inc (Class A) | Mr. Michael L Goldstone | SVP, GC and Corp. Sec. | 30 Jul 2026 | 2,100 | 0 | - | - | Option (right to buy) | ||
| Rush Enterprises Inc (Class A) | Mr. Michael L Goldstone | SVP, GC and Corp. Sec. | Sale of securities on an exchange or to another person at price $ 81.30 per share. | 30 Jul 2026 | 2,100 | 12,590 (0%) | 0% | 81.3 | 170,731 | Class A Common Stock |
| Rush Enterprises Inc (Class A) | Mr. Michael L Goldstone | SVP, GC and Corp. Sec. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.06 per share. | 30 Jul 2026 | 2,100 | 14,690 (0%) | 0% | 15.1 | 31,626 | Class A Common Stock |
| Cheesecake Factory Inc | Mr. Alexander L. Cappello | Director | Sale of securities on an exchange or to another person at price $ 101.50 per share. | 30 Jul 2026 | 2,095 | 4,076 (0%) | 0% | 101.5 | 212,643 | Common Stock |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 525.80 per share. | 30 Jul 2026 | 2,084 | 324,883 (0%) | 0% | 525.8 | 1,095,763 | Common Stock |
| Datadog Inc (Class A) | Mr. Amit Agarwal | Director | Sale of securities on an exchange or to another person at price $ 265.27 per share. | 30 Jul 2026 | 2,047 | 18,993 (0%) | 0% | 265.3 | 543,007 | Class A Common Stock |
| Groupon Inc | Ms. Kyle Netzly | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.89 per share. | 30 Jul 2026 | 2,045 | 33,872 (0%) | 0% | 27.9 | 57,035 | Common Stock |
| World Acceptance Corp | Mr. John L. Calmes, Jr | See remarks | Sale of securities on an exchange or to another person at price $ 186.00 per share. | 30 Jul 2026 | 2,000 | 48,334 (0%) | 0% | 186 | 372,000 | COMMON STOCK, NO PAR VALUE |
| BridgeBio Pharma Inc | Ms. Maricel M. Apuli | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 80.06 per share. | 30 Jul 2026 | 2,000 | 127,401 (0%) | 0% | 80.1 | 160,120 | Common Stock |
| Enphase Energy | Mr. Richard Mora | Director | Sale of securities on an exchange or to another person at price $ 36.76 per share. | 30 Jul 2026 | 2,000 | 11,922 (0%) | 0% | 36.8 | 73,520 | Common Stock |
| Jetblue Airways Corp | Ms. Carol Ann Clements | Chief Digital & Tech Officer | Sale of securities on an exchange or to another person at price $ 5.75 per share. | 30 Jul 2026 | 2,000 | 183,896 (0%) | 0% | 5.8 | 11,500 | Common Stock |
| Crowdstrike (Class A) | Mr. George R. Kurtz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 190.00 per share. | 30 Jul 2026 | 1,895 | 8,086,282 (19%) | 0% | 190 | 360,050 | Class A common stock |
| Orange County Bancorp Inc | Mr. Gregory Sousa | EVP and Deputy CLO | Sale of securities on an exchange or to another person at price $ 38.75 per share. | 30 Jul 2026 | 1,882 | 10,572 | - | 38.8 | 72,928 | Common Stock |
| Midera Food Processing Inc | Ms. Cathy L. McCarthy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 1,870 | 11,589 | - | - | Common Stock | |
| Skyline Champion Corp | Mr. Michael B. Berman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 1,867 | 12,451 (0%) | 0% | 0 | Common Stock | |
| Skyline Champion Corp | Ms. Erin Mulligan Helgren | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 1,867 | 9,296 (0%) | 0% | 0 | Common Stock | |
| Skyline Champion Corp | Mr. Gary E. Robinette | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 1,867 | 12,332 (0%) | 0% | 0 | Common Stock | |
| Skyline Champion Corp | Mr. Nikul Patel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 1,867 | 8,546 (0%) | 0% | 0 | Common Stock | |
| Skyline Champion Corp | Ms. Mary B. Fedewa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2026 | 1,867 | 5,666 (0%) | 0% | 0 | Common Stock | |
| Rush Enterprises Inc (Class A) | Mr. Steven L. Keller | CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.06 per share. | 30 Jul 2026 | 1,822 | 86,195 (0%) | 0% | 15.1 | 27,439 | Class A Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.